NBC has ordered a second season of hit Canadian medical drama Transplant. The network acquired the drama series in May, weeks into the Covid-19 production shutdown, and it has been a huge success ratings-wise since debuting Sept. 1.
NBC has acquired a Canadian drama to help shore up its primetime schedule in a time when its own series have uncertain futures. The network has picked up Transplant, a medical drama that has delivered strong ratings for broadcaster CTV in its first season. The series, which debuted Feb. 26, is the most-watched Canadian show in the country in the current broadcast year (Canada’s networks also air a number of American shows).
